
Recommendations on diagnosis and initial treatment of patients with transplant-eligible high-risk multiple myeloma by the British Society of Haematology/UK Myeloma Society buff.ly/4bw1Nok @MyMKaiser @DrSStern @JennerMatthew @UKMyelomaSoc


Recommendations on diagnosis and initial treatment of patients with transplant-eligible high-risk multiple myeloma by the British Society of Haematology/UK Myeloma Society buff.ly/4bw1Nok @MyMKaiser @DrSStern @JennerMatthew @UKMyelomaSoc

Delighted that the @BritSocHaem @UKMyelomaSoc Good Practice Paper on the treatment of high risk transplant-eligible myeloma is now published. Many thanks to @MyMKaiser for his great input. #mmsm British Journal of Haematology | Wiley Online Library onlinelibrary.wiley.com/doi/…

Legendary @f2harrell is back at Consilium next week! Sign up here for the talk mailchi.mp/consilium-scienti… @PotardDechaine @EricLow71 @DrAmandaAdler @david_colquhoun @bogdienache @rarediseaseuk @ResurgeQuality @Richard_D_Riley @vandy_biostat @BabakWork

Great job @EMA_News @HAImedicines @TranspariMED @Meds_Alliance! Learn more here clinicaltrialsarena.com/news… @nogracias_eu @RevuePrescrire @ISRCTN @METRICStanford @Marguerite_OR @Jhickmana @EricLow71 @GustavNilsonne @NDevito1

An exciting clinical research fellow in haematology post now open at UK National Amyloidosis Centre and UCLH amyloidosis/MGCS trials clinic - see #nhsjobs - 2-3 yrs with opportunities to do a PhD at UCL. @OSociety @BritSocHaem @EHA_Hematology @ASH_hematology @LinkedIn

Everyone must come! Great science, great city, great food and you get to hang out with cool #mmsm Canadian colleague hosts :) we look forward to welcoming everyone.
This tweet is unavailable

Last chance for the #myeloma MRI quiz...
Another leap for quality-controlled WB-MRI for #myeloma . Huge opportunity for better imaging data in trials and their analysis. Amazing collaboration @CTRUmyeloma , thanks @JanssenEMEA @bmsnews for support. Interested in myeloma WB-MRI? see poll tweetorial below 👇 1/10

Join us for a special event to depict HTA methodology and celebrate the legacy of Dr.Eli Gajraj. Sign up here: mailchi.mp/consilium-scienti… @FrancoisMaignen @JacolineBouvy @SirAndrewDillon @dollendorf @OortwijnW @decide_health @NICESciAdvice @EUnetHTA @EricLow71 @pilarpinilladom

Many thanks, very kind. Deeply feel we should discuss the value of extended upfront risk molecular diagnostic tests more in #myeloma , not only price. We might find that they will help allocate other rare resources like imaging or MRD tests throughout treatment phases better.
Saving the best till last! Love @MyMKaiser talk at #ims23, Importance of co-occurrence of HRCA and relevance of GEP. We have the tools but we seem unable to translate and adopt. Also need to move from understanding biology to novel therapeutic strategies for truly HR MM!

Don't read? Well, here is the podcast: labiotech.eu/podcast/beyond-…
$50 billion a year is spent on failed cancer drug development by the pharma industry. Our new paper is a case study on what goes wrong. @consiliumsci @Jhickmana jamanetwork.com/journals/jam…

Join Consilium on June 16th for a talk from our brilliant AdBoard member Jack Scannell. Sign up here: mailchi.mp/consilium-scienti… @Jhickmana @rkessler05 @RevuePrescrire @david_colquhoun @LSEHealthPolicy @HealthSenseUK @TranspariMED @HAImedicines @EricLow71 @Anticancerfund

$50 billion a year is spent on failed cancer drug development by the pharma industry. Our new paper is a case study on what goes wrong. @consiliumsci @Jhickmana jamanetwork.com/journals/jam…

If you missed a brilliant talk by @DrDavidHealy at Consilium, watch here youtu.be/Jby3xtEVm0g @riotscience_wlv @UKRIO @uaem @Jhickmana @eturnermd1 @EricLow71 @NaudetFlorian @susan_bewley @pash22 @HealthSenseUK @pssd_awareness @cheesyredrocket @PatrickChance @PatientStormDoc

Join to learn the results of the Consilium’s @MyelomaEurope funded project on QoL in multiple myeloma trials @Care4Access @KateEMor_ @drkevinknopf @MyMKaiser @FrancoisMaignen @EricLow71 @MyelomaUK @patvocates @Jhickmana @peterbachmd @AaronGoodman33 @VincentRK @pash22 @IMFmyeloma

If you missed an excellent talk on multi-modal cancer screening tests by @paulpharoah last week, watch here youtu.be/XSS1wk32bgw @ecancer @drkevinknopf @oncology_bg @EAEisenhauer @MyMKaiser @EricLow71 @EuropeanCancer @CRUK_Policy

If you missed an excellent live debate organised by @TranspariMED on how the UK trial transparency system can be implemented in other countries, watch here youtu.be/ubTcjbpfoU8 @cmarctaylor @Strech_Da @NDevito1 @HRA_Latest @matt_westmore @berlinnovation @EricLow71 @Jhickmana